Aspirin and indomethacin exhibit antiproliferative effects and induce apoptosis in T98G human glioblastoma cells

Neurological Research

Volumn 25, Issue 4, 2003, Pages 370-376

  Amin, Ruhul ^a   Kamitani, Hideki ^a   Sultana, Habiba ^a   Taniura, Seijiro ^a   Islam, Azharul ^a   Sho, Atsuko ^a   Ishibashi, Minako ^a   Eling, Thomas E ^b   Watanabe, Takashi ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Apoptosis; Chemoprevention; COX; NSAIDs; T98G

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ASSAY; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MITOSIS INHIBITION; NICK END LABELING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; ASPIRIN; CELL DIVISION; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLIOBLASTOMA; HUMANS; IN SITU NICK-END LABELING; INDOMETHACIN; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0038015542     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164103101201706     Document Type: Article

References (33)

1. Black PM. Brain tumor. Part 2. N Engl J Med 1991; 324: 1555-1564
2. Vega F, Davila L, Chatellier G, Chiras J, Fauchon F, Cornu P, Capelle L, Poisson M, Delattre JY. Treatment of malignant gliomas with surgery, intra-arterial chemotherapy with ACNU and radiation therapy. J NeuroOncol 1992; 13: 131-135
3. Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Owens G. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980; 303: 1323-1329
4. Weingart J, Brem H. Biology and therapy of glial tumors. Curr Opin Neurol Neurosurg 1992; 5: 808-812
5. Ogino M, Hisatomi H, Murata M, Hanazono M. Indomethacin suppresses the growth of colon 26, Meth-A and FM3A tumors in mice by reducing the prostaglandin E2 content and telomerase activity in tumor tissues. Jpn J Cancer Res 1999; 90: 758-764
6. Ruschoff J, Wallinger S, Dietmaier W, Bocker T, Brockhoff G, Hofstadter F, Fishel R. Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proc Natl Acad Sci USA 1998; 95: 11301-11306
7. Smith ML, Hawcroft G, Hull MA. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: Evidence of different mechanisms of action. Eur J Cancer 2000; 36: 664-674
8. Shiff SJ, Qiao L, Tsai LL, Rigas B. Sulindac sulfide, an aspirin-like compound inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 1995; 96: 491-503
9. Li M, Lotan R, Levin B, Tahara E, Lippman SM, Xu XC. Aspirin induction of apoptosis in esophageal cancer: A potential for chemoprevention. Cancer Epidemiol Biomarkers Prev 2000; 9: 545-549
10. Wong BC, Zhu GH, Lam SK. Aspirin induced apoptosis in gastric cancer cells. Biomed Pharmacother 1999; 53: 315-331
11. Zhu GH, Wong BC, Ching CK, Lai KC, Lam SK. Differential apoptosis by indomethacin in gastric epithelial cells through the constitutive expression of wild-type p53 and/or up-regulation of c-myc. Biochem Pharmacol 1999; 58: 193-200
12. Levy GN. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB J 1997; 11: 234-247
13. O'Neill GP, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 1993; 330: 156-160
14. Morita I, Schindler M, Regier MK, Otto JC, Hori T, DeWitt DL, Smith WL. Different intra-cellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem 1995; 270: 10902-10908
15. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993; 90: 11693-11697
16. Molina MA, Sitja-Arnau M, Lemoine MG, Frazier ML, Sinicrope FA. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res 1999; 59: 4356-4362
17. Deininger MH, Weller M, Streffer J, Mittelbronn M, Meyermann R. Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo. Acta Neuropathol (Berl) 1999; 98: 240-244
18. Roller A, Bahr OR, Streffer J, Winter S, Heneka M, Deininger M, Meyermann R, Naumann U, Gulbins E, Weller M. Selective potentiation of drug cytotoxicity by NSAID in human glioma cells: The role of COX-1 and MRP. Biochem Biophys Res Commun 1999; 259: 600-605
19. Joki T, Heese O, Nikas DC, Bello L, Zhang J, Kraeft SK, Seyfried NT, Abe T, Chen LB, Carroll RS, Black PM. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 2000; 60: 4926-4931
20. Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF. Cyclooxygenase-2 expression in human gliomas: Prognostic significance and molecular correlations. Cancer Res 2001; 61: 4375-4381
21. Tanaka S, Kamitani H, Amin MR, Watanabe T, Oka H, Fujii K, Nagashima T, Hori T. Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes. J NeuroOncol 2000; 46: 157-171
22. Gottlieb S. COX-2 inhibitors might be useful in cancer prevention. Brit Med J 1999; 319: 1155
23. Davies NM, Gudde TW, de Leeuw MA. Celecoxib: A new option in the treatment of arthropathies and familial adenomatous polyposis. Expert Opin Pharmacother 2001; 2: 139-152
24. Blomgren H, Kling-Andersson G. Growth inhibition of human malignant glioma cells in vitro by agents which interfere with biosynthesis of eicosanoids. Anti-cancer Res 1992; 12: 981-986
25. Aas AT, Tonnessen TI, Brun A, Salford LG. Growth inhibition of rat glioma cells in vitro and in vivo by aspirin. J NeuroOncol 1995; 24: 171-180
26. Bellosillo B, Pique M, Barragan M, Castano E, Villamor N, Colomer D, Montserrat E, Pons G, Gil J. Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 1998; 92: 1406-1414
27. Insel PA. Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's The pharmacological Basis of Therapeutics, New York: McGraw-Hill, 1996: pp. 617
28. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994; 121: 241-246
29. Eli Y, Przedecki F, Levin G, Kavir N, Raz A. Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivo. Biocheml Pharmacol 2001; 61: 565-571
30. Murphy VJ, Yang Z, Rorison KA, Baldwin GS. Cyclooxygenase-2-selective antagonists do not inhibit growth of colorectal carcinoma cell lines. Cancer Lett 1998; 122: 25-30
31. Watson AJ. Chemopreventive effects of NSAIDs against colorectal cancer regulation of apoptosis and mitosis by COX-1 and COX-2. Histol Histopathol 1998; 13: 591-597
32. Herrmann C, Block C, Geisen C, Haas K, Weber G, Winde G, Moroy T, Muller O. Sulindac sulfide inhibits Ras signaling. Oncogene 1998; 17: 1769-1776
33. Baek SJ, Kim KS, Nixon JB, Wilson LC, Eling TE. Cyclooxygenase inhibitors regulate the expression of a TGF-β superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 2001; 59: 901-908